Prospectus • Nov 10, 2017
Prospectus
Open in ViewerOpens in native device viewer
November 10, 2017 Gothenburg, Sweden
Getinge's wholly-owned subsidiary Arjo AB (publ) has prepared a prospectus regarding the admission to trading of the company's shares of series B. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority. Similar to Getinge's shares of series A, Arjo's shares of series A will not be listed.
The prospectus can be obtained from Getinge and SEB and is available at Getinge's website, www.getinge.com and at SEB's website for prospectuses, www.sebgroup.com/prospectuses.
Lars Mattsson, Getinge Head of Investor Relations Telephone: +46(0)10 335 00 43 E-mail: [email protected]
Kornelia Rasmussen, Arjo Executive Vice President Marketing Communication and Public Relations Telephone: +46 (0)10 335 58 10 E-mail: [email protected]
Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving everyday life for people, today and tomorrow.
Getinge AB Box 8861 402 72 Gothenburg Sweden
Telephone: +46 (0)10 335 00 00 Email: [email protected]
www.getinge.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.